|
|||||||
|
Researchers have determined that a number of environmental factors, including trauma, are related to the onset of psoriatic arthritis in patients who have psoriasis. Dr. Ian N. Bruce, of the University of Manchester, UK, and his team investigated 98 patients with psoriasis who had developed inflammatory arthritis. These were compared to 163 psoriasis patients [...] Rheumatoid arthritis (RA) is an auto-immune disease marked by inflammation of the joints and surrounding tissue. Psoriatic arthritis is a condition related to psoriasis, a chronic skin condition that is also an auto-immune disease. Psoriatic arthritis is usually confined to the knees, ankles, and joints in the feet. Treatment for psoriatic arthritis has generally [...] The FDA has received 30 reports of cancer in children under the age of 18 who had been treated for JIA with anti-TNF drugs along with other medications, such as methotrexate, or similar immunosuppressant drugs. [...] A recent review of treatments for Psoriatic arthritis (PsA) found that the benefit of different therapies depended how widespread the disease was. Psoriatic arthritis is the second most common cause of joint inflammation. It involves the skin and joints, but may also affect fingers and toes, eyes and the spine. The effect on the [...] Psoriatic arthritis is a joint disease developed by and estimated 20 to 40 percent of psoriasis patients. Detecting the disease in the early stages can provide an opportunity to administer treatments that can lessen the damage to the joints. Pharmaceutical company PharmaGenoma, through its subsidiary PsoriasisDx, has developed a genetic test to assist [...] Monday was global Psoriasis Awareness Day which lead me to research for today’s post. Psoriasis is an autoimmune disease that causes redness, itching, scaling and inflammation of the skin and inflammation of the joints, a condition known as psoriatic arthritis. Psoriatic arthritis affects up to 15% of people with psoriasis. Psoriasis is not contagious [...] The FDA ordered that the class of drugs known as TNF blockers carry a warning on the packaging that their use carries the risk of developing a potentially deadly fungal disease called histoplasmosis. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
